These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24530272)

  • 1. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
    Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
    Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
    Belzil VV; Bauer PO; Prudencio M; Gendron TF; Stetler CT; Yan IK; Pregent L; Daughrity L; Baker MC; Rademakers R; Boylan K; Patel TC; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):895-905. PubMed ID: 24166615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
    Gendron TF; Bieniek KF; Zhang YJ; Jansen-West K; Ash PE; Caulfield T; Daughrity L; Dunmore JH; Castanedes-Casey M; Chew J; Cosio DM; van Blitterswijk M; Lee WC; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):829-44. PubMed ID: 24129584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
    Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E
    Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier.
    Russ J; Liu EY; Wu K; Neal D; Suh E; Irwin DJ; McMillan CT; Harms MB; Cairns NJ; Wood EM; Xie SX; Elman L; McCluskey L; Grossman M; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2015 Jan; 129(1):39-52. PubMed ID: 25388784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells.
    Bauer PO
    Neurosci Lett; 2016 Jan; 612():204-209. PubMed ID: 26690922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
    Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
    Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
    Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
    Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
    Glasmacher SA; Wong C; Pearson IE; Pal S
    JAMA Neurol; 2020 Mar; 77(3):367-376. PubMed ID: 31738367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.
    Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ
    Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72.
    Savica R; Adeli A; Vemuri P; Knopman DS; Dejesus-Hernandez M; Rademakers R; Fields JA; Whitwell J; Jack CR; Lowe V; Petersen RC; Boeve BF
    Arch Neurol; 2012 Sep; 69(9):1164-9. PubMed ID: 22637471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.
    Suh E; Lee EB; Neal D; Wood EM; Toledo JB; Rennert L; Irwin DJ; McMillan CT; Krock B; Elman LB; McCluskey LF; Grossman M; Xie SX; Trojanowski JQ; Van Deerlin VM
    Acta Neuropathol; 2015 Sep; 130(3):363-72. PubMed ID: 26022924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.